Desmopressin Combined with a Polymer Forms Nanostructures That Selectively Inhibit Aggressive Breast Cancer Cells

Desmopressin, a synthetic peptide analog of vasopressin, self-assembles with the polymer sodium polystyrene sulfonate (NaPSS) to form hybrid fibrillar nanostructures enriched in β-turn and β-sheet domains. When tested against breast cancer cell lines, these peptide-polymer complexes were well-tolerated by non-metastatic MCF-7 cells but showed inhibitory effects against the highly metastatic MDA-MB-231 cells, suggesting selective anticancer activity.

The researchers used advanced structural imaging techniques — small-angle X-ray scattering (SAXS), cryo-electron microscopy, and atomic force microscopy with infrared nanospectroscopy — to characterize how desmopressin and NaPSS self-assemble together. They then tested the resulting complexes on two breast cancer cell lines (non-metastatic MCF-7 and metastatic MDA-MB-231) using in vitro cytotoxicity assays.

Desmopressin is already an FDA-approved drug used for diabetes insipidus and bleeding disorders, and there is growing interest in repurposing it as a cancer treatment. This study shows that combining it with another approved drug (NaPSS) creates nanostructures that selectively target aggressive cancer cells — a promising step toward peptide-polymer nanotherapeutics built entirely from existing medications.

Peptide-polymer nanosystems are an active frontier in drug delivery, aiming to combine the targeting precision of peptides with the structural versatility of polymers. This study is notable because both components are already clinically approved drugs, potentially shortening the path from lab to patient. It also adds to the growing body of evidence that desmopressin may have anticancer properties worth exploring.

This is an in vitro study using only two cell lines, so results cannot be directly translated to cancer treatment in humans. The selective toxicity mechanism is not fully explained. No animal models or pharmacokinetic data were included, and the long-term stability and behavior of these nanoassemblies in biological environments remain unknown.